New Hepatitis C Medication Sparks Debate on Innovation and Cost
New Hepatitis C Medication Sparks Debate on Innovation and Cost
par Andrew EisnerRéflexions liées
The Pensions Regulator’s latest expectations on scheme funding (Ouvre dans un nouvel onglet)
The Pensions Regulator’s latest expectations on scheme funding (Ouvre dans un nouvel onglet)
Volume 2021 | Issue 19 Download this FYI as a printable PDF The Pensions Regulator...
Lire la suit : The Pensions Regulator’s latest expectations on scheme funding (Ouvre dans un nouvel onglet)
DOL issues cybersecurity guidance for retirement plan sponsors and fiduciaries (Ouvre dans un nouvel onglet)
DOL issues cybersecurity guidance for retirement plan sponsors and fiduciaries (Ouvre dans un nouvel onglet)
While cybercrime was already on the rise prior to 2020, its acceleration during the...
Lire la suit : DOL issues cybersecurity guidance for retirement plan sponsors and fiduciaries (Ouvre dans un nouvel onglet)
Restricting the statutory right to transfer (Ouvre dans un nouvel onglet)
Restricting the statutory right to transfer (Ouvre dans un nouvel onglet)
Volume 2021 | Issue 17 Download this FYI as a printable PDF Trustees and providers...
Lire la suit : Restricting the statutory right to transfer (Ouvre dans un nouvel onglet)